Prothena Corporation PLC
General ticker "PRTA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $775.0M
Prothena Corporation PLC does not follow the US Stock Market performance with the rate: -31.0%.
Estimated limits based on current volatility of 8.0%: low 13.86$, high 16.26$
Factors to consider:
- Current price 21.9% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [19.64$, 43.03$]
- 2024-12-30 to 2025-12-30 estimated range: [13.67$, 31.20$]
Financial Metrics affecting the PRTA estimates:
- Negative: Non-GAAP EPS, $ of -2.80 <= 0.10
- Negative: Operating profit margin, % of -67.65 <= 1.03
- Negative: Operating cash flow per share per price, % of -6.49 <= 2.35
- Negative: negative Net income
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
Short-term PRTA quotes
Long-term PRTA plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $200.58MM | $53.91MM | $91.37MM |
| Operating Expenses | $128.60MM | $185.46MM | $282.41MM |
| Operating Income | $71.97MM | $-131.56MM | $-191.04MM |
| Non-Operating Income | $-0.05MM | $5.95MM | $30.56MM |
| R&D Expense | $82.28MM | $135.56MM | $220.57MM |
| Income(Loss) | $71.92MM | $-125.61MM | $-160.48MM |
| Taxes | $4.95MM | $-8.66MM | $-13.45MM |
| Profit(Loss) | $66.97MM | $-116.95MM | $-147.03MM |
| Stockholders Equity | $466.04MM | $622.04MM | $561.37MM |
| Inventory | $0.01MM | $0.06MM | $0.00MM |
| Assets | $609.37MM | $758.03MM | $696.38MM |
| Operating Cash Flow | $92.61MM | $-108.82MM | $-133.91MM |
| Capital expenditure | $0.57MM | $0.46MM | $2.81MM |
| Investing Cash Flow | $-0.57MM | $-0.46MM | $-2.77MM |
| Financing Cash Flow | $190.33MM | $241.46MM | $45.10MM |
| Earnings Per Share* | $1.51 | $-2.47 | $-2.76 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.